Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Apr;61(4):626–630. doi: 10.1038/bjc.1990.139

Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma.

M Mottolese 1, I Venturo 1, G Digiesi 1, R Perrone Donnorso 1, A Bigotti 1, R Muraro 1, A Aluffi 1, P G Natali 1
PMCID: PMC1971368  PMID: 2184879

Abstract

During the course of colon-rectum tumours a number of clinical events may occur in which conventional cytopathology can provide only a partial contribution to the definition of a differential diagnosis, i.e. effusions, distant recurrences and second neoplasias. In the present study we have evaluated whether monoclonal antibody (MoAb) D612, recognising a colon-rectum associated antigen, can be used in this context. To this end, MoAb D612 was employed in combination with a panel of MoAb of well defined tumour specificity in immunocytochemical tests. The immunocytochemical findings obtained were compared with the histological and clinical diagnosis. Of 62 effusions and 40 fine needle aspirates studied, MoAb D612 reactivity correlated with the correct diagnosis in 92.8% of the instances. These results indicate that this reagent may help to improve the current cytopathological diagnosis of colon-rectum tumours by identifying the colonic origin of metastases in patients with unknown primary tumour, differentiating ovarian carcinoma from colon metastases to the ovaries and establishing the presence of a second neoplasia in patients with a previous history other than colon carcinoma.

Full text

PDF
629

Images in this article

628Figure 1
on p.628

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avrameas S., Ternynck T. The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents. Immunochemistry. 1969 Jan;6(1):53–66. doi: 10.1016/0019-2791(69)90178-5. [DOI] [PubMed] [Google Scholar]
  2. Bast R. C., Jr, Feeney M., Lazarus H., Nadler L. M., Colvin R. B., Knapp R. C. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981 Nov;68(5):1331–1337. doi: 10.1172/JCI110380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cahan W. G., Castro E. B., Hajdu S. I. Proceedings: The significance of a solitary lung shadow in patients with colon carcinoma. Cancer. 1974 Feb;33(2):414–421. doi: 10.1002/1097-0142(197402)33:2<414::aid-cncr2820330216>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  4. Colcher D., Hand P. H., Nuti M., Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci U S A. 1981 May;78(5):3199–3203. doi: 10.1073/pnas.78.5.3199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dixon A. K., Fry I. K., Morson B. C., Nicholls R. J., Mason A. Y. Pre-operative computed tomography of carcinoma of the rectum. Br J Radiol. 1981 Aug;54(644):655–659. doi: 10.1259/0007-1285-54-644-655. [DOI] [PubMed] [Google Scholar]
  6. Ghosh A. K., Spriggs A. I., Taylor-Papadimitriou J., Mason D. Y. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. J Clin Pathol. 1983 Oct;36(10):1154–1164. doi: 10.1136/jcp.36.10.1154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gianola F. J., Dwyer A., Jones A. E., Sugarbaker P. H. Prospective studies of laboratory and radiologic tests in the management of colon and rectal cancer patients: I. Selection of useful preoperative tests through an analysis of surgically occult metastases. Dis Colon Rectum. 1984 Dec;27(12):811–818. doi: 10.1007/BF02553945. [DOI] [PubMed] [Google Scholar]
  8. Hilborne L. H., Cheng L., Nieberg R. K., Lewin K. J. Evaluation of an antibody to human milk fat globule antigen in the detection of metastatic carcinoma in pleural, pericardial and peritoneal fluids. Acta Cytol. 1986 May-Jun;30(3):245–250. [PubMed] [Google Scholar]
  9. Hsu S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981 Apr;29(4):577–580. doi: 10.1177/29.4.6166661. [DOI] [PubMed] [Google Scholar]
  10. Johnston W. W., Szpak C. A., Lottich S. C., Thor A., Schlom J. Use of a monoclonal antibody (B72.3) as a novel immunohistochemical adjunct for the diagnosis of carcinomas in fine needle aspiration biopsy specimens. Hum Pathol. 1986 May;17(5):501–513. doi: 10.1016/s0046-8177(86)80041-7. [DOI] [PubMed] [Google Scholar]
  11. Johnston W. W., Szpak C. A., Lottich S. C., Thor A., Schlom J. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions. Cancer Res. 1985 Apr;45(4):1894–1900. [PubMed] [Google Scholar]
  12. Kyrkou K. A., Iatridis S. G., Athanassiadou P. P., Emmanouilidou A. G., Athanassiadis P. P. Detection of benign or malignant origin of ascites with combined indirect immunoperoxidase assays of carcinoembryonic antigen and lysozyme. Acta Cytol. 1985 Jan-Feb;29(1):57–62. [PubMed] [Google Scholar]
  13. Lash R. H., Hart W. R. Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases. Am J Surg Pathol. 1987 Feb;11(2):114–121. doi: 10.1097/00000478-198702000-00005. [DOI] [PubMed] [Google Scholar]
  14. Martin S. E., Moshiri S., Thor A., Vilasi V., Chu E. W., Schlom J. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3. Am J Clin Pathol. 1986 Jul;86(1):10–18. doi: 10.1093/ajcp/86.1.10. [DOI] [PubMed] [Google Scholar]
  15. Mazur M. T., Hsueh S., Gersell D. J. Metastases to the female genital tract. Analysis of 325 cases. Cancer. 1984 May 1;53(9):1978–1984. doi: 10.1002/1097-0142(19840501)53:9<1978::aid-cncr2820530929>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  16. Miotti S., Canevari S., Ménard S., Mezzanzanica D., Porro G., Pupa S. M., Regazzoni M., Tagliabue E., Colnaghi M. I. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity. Int J Cancer. 1987 Mar 15;39(3):297–303. doi: 10.1002/ijc.2910390306. [DOI] [PubMed] [Google Scholar]
  17. Morrow M., Enker W. E. Late ovarian metastases in carcinoma of the colon and rectum. Arch Surg. 1984 Dec;119(12):1385–1388. doi: 10.1001/archsurg.1984.01390240023004. [DOI] [PubMed] [Google Scholar]
  18. Mottolese M., Venturo I., Donnorso R. P., Curcio C. G., Rinaldi M., Natali P. G. Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin. Eur J Cancer Clin Oncol. 1988 Aug;24(8):1277–1284. doi: 10.1016/0277-5379(88)90215-5. [DOI] [PubMed] [Google Scholar]
  19. Muraro R., Nuti M., Natali P. G., Bigotti A., Simpson J. F., Primus F. J., Colcher D., Greiner J. W., Schlom J. A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epithelium. Int J Cancer. 1989 Apr 15;43(4):598–607. doi: 10.1002/ijc.2910430411. [DOI] [PubMed] [Google Scholar]
  20. Ménard S., Rilke F., Della Torre G., Mariani-Costantini R., Regazzoni M., Tagliabue E., Alasio L., Colnaghi M. I. Sensitivity enhancement of the cytologic detection of cancer cells in effusions by monoclonal antibodies. Am J Clin Pathol. 1985 May;83(5):571–576. doi: 10.1093/ajcp/83.5.571. [DOI] [PubMed] [Google Scholar]
  21. Nouwen E. J., Pollet D. E., Eerdekens M. W., Hendrix P. G., Briers T. W., De Broe M. E. Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung. Cancer Res. 1986 Feb;46(2):866–876. [PubMed] [Google Scholar]
  22. Orell S. R., Dowling K. D. Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions. Acta Cytol. 1983 Nov-Dec;27(6):625–629. [PubMed] [Google Scholar]
  23. Osamura R. Y., Watanabe K., Akatsuka Y. Peroxidase-labeled antibody staining for carcinoembryonic antigen of cytologic specimens for light and electron microscopy. Acta Cytol. 1985 May-Jun;29(3):254–256. [PubMed] [Google Scholar]
  24. Ramaekers F., Haag D., Jap P., Vooijs P. G. Immunochemical demonstration of keratin and vimentin in cytologic aspirates. Acta Cytol. 1984 Jul-Aug;28(4):385–392. [PubMed] [Google Scholar]
  25. Russo C., Callegaro L., Lanza E., Ferrone S. Re.: Purification of IgG monoclonal antibody by caprylic acid precipitation. J Immunol Methods. 1983 Dec 16;65(1-2):269–271. doi: 10.1016/0022-1759(83)90324-1. [DOI] [PubMed] [Google Scholar]
  26. Sakakibara K., Ueda R., Ohta M., Nakashima N., Tomoda Y., Takahashi T. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors. Cancer Res. 1988 Aug 15;48(16):4639–4645. [PubMed] [Google Scholar]
  27. Szpak C. A., Johnston W. W., Lottich S. C., Kufe D., Thor A., Schlom J. Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1 and B6.2) with cells in human malignant and benign effusions. Acta Cytol. 1984 Jul-Aug;28(4):356–367. [PubMed] [Google Scholar]
  28. Thor A., Ohuchi N., Szpak C. A., Johnston W. W., Schlom J. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res. 1986 Jun;46(6):3118–3124. [PubMed] [Google Scholar]
  29. To A., Dearnaley D. P., Ormerod M. G., Canti G., Coleman D. V. Epithelial Membrane Antigen. Its use in the cytodiagnosis of malignancy in serous effusions. Am J Clin Pathol. 1982 Aug;78(2):214–219. doi: 10.1093/ajcp/78.2.214. [DOI] [PubMed] [Google Scholar]
  30. Varki N. M., Reisfeld R. A., Walker L. E. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies. Cancer Res. 1984 Feb;44(2):681–687. [PubMed] [Google Scholar]
  31. Waneck R., Lechner G., Jantsch H., Kovats E., Schiessel R. Lateral distant view for improved accuracy in locating rectal tumors. AJR Am J Roentgenol. 1984 Mar;142(3):519–523. doi: 10.2214/ajr.142.3.519. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES